The sublingual vaccine MV140 is dominant over prophylactic antibiotics for the prevention of recurrent, uncomplicated urinary tract infections in adult women A cost-utility analysis.
Saved in:
| Title: | The sublingual vaccine MV140 is dominant over prophylactic antibiotics for the prevention of recurrent, uncomplicated urinary tract infections in adult women A cost-utility analysis. |
|---|---|
| Authors: | Doiron, R. Christopher1, Nickel, J. Curtis1, Kamdar, Shivani2 |
| Source: | Canadian Urological Association Journal. May2026, Vol. 20 Issue 5, p54-62. 9p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
